Trial · NCT03329287
Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
NCT03329287, Not applicable, Unknown, Shanghai Mental Health Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression. Trials, record NCT03329287. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03329287
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
- NCT number
- NCT03329287
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 180 participants, estimated
- Lead sponsor
- Shanghai Mental Health Center
- Conditions
- Generalized Anxiety Disorder, Major Depressive Disorder
- Interventions
- SCBT, SSRIs and/or SNRIs, Psychological Placebo
- First posted
- 2017-11-01
- Last updated
- 2017-11-01
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | changes of The Hamilton Depression Scale (HAMD-17) | At baseline, 2-week, 4-week, 6-week, 8-week, 12-week, 20-week, 32-week and 56-week. | Scale total range is 52. Lower score represents a better outcome. |
| Primary | changes of The Hamilton Anxiety Scale (HAMA-14) | At baseline, 2-week, 4-week, 6-week, 8-week, 12-week, 20-week, 32-week and 56-week. | Scale total range is 56. Lower score represents a better outcome. |
| Secondary | changes of The Patient Health Questionnaire (PHQ-9) | At baseline, 2-week, 4-week, 6-week, 8-week, 12-week, 20-week, 32-week and 56-week. | Scale total range is 27. Lower score represents a better outcome. |
| Secondary | changes of The GAD-7 | At baseline, 2-week, 4-week, 6-week, 8-week, 12-week, 20-week, 32-week and 56-week. | Scale total range is 21. Lower score represents a better outcome. |
| Secondary | changes of The Mos 36-item Short Form Health Survey (SF-36) | At baseline, 4-week, 8-week, 12-week, 20-week, 32-week and 56-week. | It has nine dimensions, each dimension has an independent fractional formula. |
| Secondary | changes of Treatment Emergent Symptom Scale (TESS) | At baseline, 2-week, 4-week, 6-week, 8-week, 12-week, 20-week, 32-week and 56-week. | Evaluation of side effects caused by various psychotropic drugs. |
| Secondary | changes of Clinical Global Impression (CGI) | At baseline, 2-week, 4-week, 6-week, 8-week, 12-week, 20-week, 32-week and 56-week. | Evaluation of clinical efficacy. Lower score represents a better outcome. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03329287
GET https://conductscience.org/api/trials/v1/NCT03329287/registered